Product information

From Health Canada

New search

Current status:

Marketed

Current status date:

2018-06-20

Original market date: See footnote 1

2018-06-20

Product name:

ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD) FORMULA A

Description:

FOR USE ONLY WITH APHERESIS DEVICES

DIN:

02469731 Electronic product monograph is not available

Company: 

TERUMO BCT, INC.
10811 W Collins Ave
Lakewood
Colorado
United States  80215

Class: 

Human

Dosage form(s):

Solution

Route(s) of administration:

0-Unassigned

Number of active ingredient(s):

3

Schedule(s):

Ethical  

Biosimilar Biologic Drug:

No

American Hospital Formulary Service (AHFS): See footnote 3

20:12.04.92   MISCELLANEOUS ANTICOAGULANTS

Anatomical Therapeutic Chemical (ATC): See footnote 4

V07AC  BLOOD TRANSFUSION, AUXILIARY PRODUCTS

Active ingredient group (AIG) number:See footnote 5

0359691001

List of active ingredient(s)
Active ingredient(s) Strength
CITRIC ACID MONOHYDRATE 0.8 G / 100 ML
DEXTROSE 2.45 G / 100 ML
SODIUM CITRATE DIHYDRATE 2.2 G / 100 ML

Application information

Related information

Contact us

Version 3.8.0
Date modified: